Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YAZ in Chinese Patients With PMDD
NCT00824187Phase 3Completed
- Sponsor
- Bayer
- Start
- Jan 2009
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ethinyl estradiol + drospirenone in Premenstrual Dysphoric Disorder (PMDD), sponsored by Bayer. Started Jan 2009; status: completed.
02
Drugs
ethinyl estradiol + drospirenone
03
Conditions
Premenstrual Dysphoric Disorder (PMDD)
Beyond the preview
Go deeper on NCT00824187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00824187.